EUVIMEDEUVIMED entdecken
Open Access

Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling

Alexandra M Garvin iD, Dana B Floyd, Alexis C Bailey, Merry L Lindsey iD, Chad C Carroll iD, Taben M Hale iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.00753.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Alexandra M Garvin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona, United States. Hauptthemen laut MEDLINE: Angiotensin II, Angiotensin-Converting Enzyme Inhibitors, Ventricular Remodeling, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here, we determine, for the first time that female spontaneously hypertensive rats are responsive to transient angiotensin-converting enzyme inhibitor (ACEi) treatment. Prior work showed that transient ACEi treatment induced persistent protection against a future stimulus in males. Here, Ang II-induced cardiac fibrosis was attenuated by transient ACEi treatment in both sexes. Notably, the underlying mechanism of action is sex-dependent. Specifically, changes in collagen deposition in male but not female hearts correlate with collagen gene expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin IIAngiotensin-Converting Enzyme InhibitorsVentricular RemodelingHypertensionAnimalsMaleFemaleRats, Inbred SHRFibrosisRatsSex FactorsBlood PressureMyocardiumSex CharacteristicsSignal Transduction

Stichwörter der Autor:innen

angiotensincardiacfibrosishypertensionsex differences

Substanzen

Angiotensin IIAngiotensin-Converting Enzyme Inhibitors

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona, United States.
  • Department of Physiology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, United States.
  • School of Graduate Studies, Meharry Medical College, Nashville, Tennessee, United States.
  • Research Service, Nashville VA Medical Center, Nashville, Tennessee, United States.
  • Department of Health and Kinesiology, Purdue University, West Lafayette, Indiana, United States.

ORCID-Profile: Alexandra M Garvin, Merry L Lindsey, Chad C Carroll, Taben M Hale

Förderung

  • NHLBI NIH HHS
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • NIGMS NIH HHS
  • U.S. Department of Veterans Affairs (VA)
  • BLRD VA
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)

Zitieren

APA

Garvin, A. M., Floyd, D. B., Bailey, A. C., Lindsey, M. L., Carroll, C. C., & Hale, T. M. (2025). Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00753.2024

Vancouver

Garvin AM, Floyd DB, Bailey AC, Lindsey ML, Carroll CC, Hale TM. Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00753.2024

BibTeX
@article{Garvin2025,
  author = {Garvin, Alexandra M and Floyd, Dana B and Bailey, Alexis C and Lindsey, Merry L and Carroll, Chad C and Hale, Taben M},
  title = {Transient angiotensin-converting enzyme inhibition confers sex-specific protection against angiotensin II-induced cardiac remodeling},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.00753.2024}
}
Kostenlos starten →